Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
trial enrollment
Pharma
Travere pauses trial enrollment over manufacturing scale-up woes
San Diego’s Travere Therapeutics has run into trouble with its enzyme replacement candidate pegtibatinase thanks to manufacturing scale-up issues.
Fraiser Kansteiner
Sep 27, 2024 9:26am
Moderna blamed after kids sent $2,000 COVID vaccine trial offer
Sep 25, 2024 7:22am
Supply constraints force pause of BMS, RayzeBio trial enrollment
Jun 3, 2024 3:38pm
Big Pharmas back American Lung Association trial diversity push
May 30, 2023 9:30am
J&J ups takes trial diversity push with doctor, mobile clinic
Oct 4, 2022 9:30am